Back to Trades
Total Value
$7.8M
Net $5.2M sold
Filing Date
Jul 9, 2026
8 transactions
Sales
$5.2M
8 transactions
Trade Summary
On Jul 9, 2026, ROTHBLATT MARTINE A, Insider, sold $7.8M of UNITED THERAPEUTICS Corp (UTHR) across 8 transactions. The filing covers Common Stock and reflects net selling of $5.2M. Reported prices ranged from $135.42 to $555.76. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- UNITED THERAPEUTICS Corp
- Ticker Symbol
- UTHR
- CIK
- 0001082554
Insider Information
- Role
- Insider
- Location
- SILVER SPRING, MD
Filing Details
- Filing Date
- Jul 9, 2026
- Transaction Date
- Jul 9, 2026
- Accession Number
- 0001106578-26-000095
- Form Type
- 4
- Net Trading Amount
- -$5.2M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 9, 2026 | Common Stock | 9,500 | $135.42 | Exercise | $1.3M |
| Jul 9, 2026 | Common Stock | 440 | $548.16 | Sale | $241.2K |
| Jul 9, 2026 | Common Stock | 1,536 | $549.01 | Sale | $843.3K |
| Jul 9, 2026 | Common Stock | 1,452 | $550.12 | Sale | $798.8K |
| Jul 9, 2026 | Common Stock | 2,863 | $551.03 | Sale | $1.6M |
| Jul 9, 2026 | Common Stock | 1,648 | $552.38 | Sale | $910.3K |
| Jul 9, 2026 | Common Stock | 801 | $553.29 | Sale | $443.2K |
| Jul 9, 2026 | Common Stock | 640 | $554.23 | Sale | $354.7K |
| Jul 9, 2026 | Common Stock | 120 | $555.76 | Sale | $66.7K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 9, 2026 | UTHR derivative | 9,500 | $135.42 | Exercise | $1.3M |
Want live alerts when ROTHBLATT MARTINE A trades again?
Download Insider Trades to track UTHR, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- (F2)This transaction was executed in multiple trades at prices ranging from $547.61 to $548.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F3)This transaction was executed in multiple trades at prices ranging from $548.66 to $549.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F4)This transaction was executed in multiple trades at prices ranging from $549.69 to $550.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F5)This transaction was executed in multiple trades at prices ranging from $550.70 to $551.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F6)This transaction was executed in multiple trades at prices ranging from $551.81 to $552.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F7)This transaction was executed in multiple trades at prices ranging from $552.84 to $553.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F8)This transaction was executed in multiple trades at prices ranging from $553.84 to $554.565. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F9)This transaction was executed in multiple trades at prices ranging from $555.75 to $555.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F10)Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- (F11)Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- (F12)Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- (F13)Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- (F14)Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.